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Abstract: The stem bark of Croton gratissimus (Euphorbiaceae)  yielded four novel 
cembranolides, including the first reported example of a 2,12-cyclocembranolide, 
(+)–[1R*,2S*,7S*,8S*,12R*]–7,8-epoxy-2,12-cyclocembra-3E,10Z-dien-20,10-olide, 
whose structure was confirmed by means of single crystal X-ray analysis.  This 
compound showed moderate activity against the PEO1 and PEO1TaxR ovarian cancer 
cell lines.   
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1. Introduction: 
Of the approximately 750 species of Croton L. (Euphorbiaceae) distributed 
throughout the tropics, some 50 are found in Africa (Mabberley 2008), and only 10 
species are native to the Flora of southern Africa region. Croton gratissimus Burch. 
(syn. C. zambesicus Müll. Arg.; C. microbotryus Pax.) is represented by two varieties, 
the typical one (C. gratissimus Burch. var. gratissimus) being the subject of this 
account. This semi-deciduous tree species is widespread in sub-Saharan Africa, 
occurring on stony or rocky hillsides throughout much of the warmer and drier 
regions, from South Africa northeastwards to the horn of Africa. The leaves produce a 
pleasant lavender-like scent when crushed, and are used dried and powdered for their 
perfume (Palmer and Pitman, 1972). Across its range it is an important 
ethnomedicinal species: the Zulu use milk infusions of the bark as purgatives for 
stomach and intestinal disorders, despite its toxic reputation (Bryant, 1966). 
Elsewhere several other crotons including the Asian C. tiglium L., and C. flavens L. 
from the Caribbean have been so employed, although diterpenes from both have been 
implicated in indirect carcinogenesis (oesophageal cancer) through activation of the 
Epstein-Barr virus (Hecker, 1981; Bruneton, 1995). The Zulu further treat unspecified 
uterine disorders with powdered bark blown into the womb. They also remedy 
pleurisy or pleurodynia by rubbing the powdered bark into chest skin incisions to act 
as a counter-irritant, given its cutaneous eruptive irritant and stimulant properties 
(Bryant 1966). As a cure for insomnia and restlessness, the leaves are ground with 
goat fat and those of two other Croton species, the paste heated on coals and the 
fumes inhaled (Palmer and Pitman, 1972). Gerstner (1941) further recorded the 
purgative properties of the roots, and documented their application in treating fevers. 
Zimbabweans treat coughs with smoke from leaves, and take root infusions for 
abdominal pains and as an aphrodisiac (Gelfand et al., 1985). In Botswana a 
decoction prepared with leaves is taken for coughs (Hedberg and Staugård, 1989). 
Watt and Breyer-Brandwijk (1962) documented the use of C. gratissimus bark in 
treating painful respiratory conditions (including intercostal neuralgia), unspecified 
plant parts as a remedy for fevers, charred, powdered bark for bleeding gums, and 
leaves to treat both eye disorders and rheumatism. In Venda, leaves are dried and 
smoked for influenza, colds and fevers (Mabogo, 1990). Doubts about the toxicity of 
this species have been raised due to the esteem with which leaves have been held as a 
stock food in Namibia (Watt and Breyer-Brandwijk, 1962).  
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In this country roots and leaves of this taxon have found application as a treatment for 
colds and coughs, bark for ear problems, and roots for chest ailments and fever (Von 
Koenen, 2001). From the above usage profiles of C. gratissimus the following diverse 
bioactivities are indicated: analgesia, febrifugal, aphrodisiac, purgative, emetic, 
soporific, antibiotic and antiviral. The febrifugal activity of C. gratissimus (in the 
context of malaria) has earlier been demonstrated: Clarkson et al. (2004) found DCM 
extracts of the leaves to show a high antiplasmodial activity in vitro of 3.5 µg/ml. In 
the current study, congnisance has been taken of the use of this species for 
unspecified abdominal pains (Gelfand et al., 1985), an indication of potential 
antineoplastic applications (Charlson, 1980), especially as the Zulu treat unspecified 
uterine disorders with powdered bark preparations (Bryant, 1966). Accordingly, 
isolates from the bark were screened against PEO1 and PEO1TaxR ovarian cancer 
cell lines. 
 
Previous investigations of the genus Croton have yielded pimarane (Block et al., 
2004), kaurane (Kuo et al., 2007 ), labdane (Garcia et al., 2006 ), clerodane (Garcia et 
al., 2006) and cembrane (Pudhom et al., 2007) diterpenoids, isoquinoline alkaloids 
(New World species only) (Charris et al., 2000 ) and triterpenoids (Block et al., 
2004).   
 
2. Results and discussion: 
The hexane and dichloromethane extracts of the stem bark of Croton gratissimus 
yielded lupeol, 4(15)-eudesmene-1,6-diol, -glutinol and four novel cembrane 
diterpenoids, 1 - 4. 
 
HREIMS of compound 1 indicated a molecular formula of C20H28O3. The IR 
spectrum showed a peak at 1777 cm-1 and a resonance at 183.6 indicating the 
presence of a carbonyl group. Interestingly, this was the only one of the four 
compounds that was very stable on standing and crystalline.  These spectroscopic 
values differed considerably from the carbonyl stretch which occurred at 1733-1740 
cm-1 in the IR spectra and at approximately 174 in the 13C NMR spectra of 
compounds 2-4.  The   13C NMR spectrum showed that compound 1 had two 
trisubstituted double bonds (128.5 (CH), 136.0 (C); 151.2 (C), 110.6 (CH)) 
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indicating, in conjunction with the molecular formula, that the molecule contained 
four rings. The 1H NMR spectrum showed the presence of two secondary methyl 
groups ( 0.85 (d, J=6.6 Hz), 0.92 (d, J=6.6 Hz)) which were ascribed to H3-16 and 
H3-17 of a cembranoid structure. These resonances were seen to be coupled to the H-
15 resonance (1.68) which was coupled further to the H-1 resonance at 1.70. The 
H-1 resonance showed further coupling with the two H-14 resonances (1.84 and 
1.67), and a single proton resonance which could be ascribed to H-2 ( 2.91, t, J = 
9.6 Hz).  The H-2 resonance showed coupling in the COSY spectrum with an alkene 
proton resonance ( 4.85, d, J=9.6 Hz) which was assigned to H-3, enabling 
placement of the first double bond at C-3. The H-3 resonance showed long range 
coupling with the H3-18 proton resonance at 1.52. The corresponding C-18 
resonance occurred at 15.1, confirming the E-configuration of the double bond 
(Lange et al., 1986).  Interestingly, the H-2 resonance showed correlations in the 
HMBC spectrum with the carbonyl carbon resonance (183.6) and the second alkene 
carbon resonance (110.6), suggesting a linkage across the cembranoid. The presence 
of an epoxide ring was suggested with resonances at 63.0 (CH) and  61.9 (C) 
leaving a methyl group, and four further methylene groups to be placed.  Use was 
made of the Logic for Structure Determination Program to complete the structure of 
the molecule and to rule out the possibility of any other possible structure.  According 
to the usual LSD protocol (Nuzillard, 2003; Nuzillard, 2008), the 13C NMR 
resonances of 1 were first identified by numbers ranging from 1 to 20, in the 
decreasing order of chemical shift values. The 1H NMR resonances were identified 
using the HSQC spectrum, so that a carbon atom and a hydrogen atom that are 
directly bonded share the same identifier. Then, a status was assigned to each atom, 
which is defined by its chemical element, its hybridization state and the number of 
bonded hydrogen atoms (also named, multiplicity). Only the carbon atoms whose 
chemical shift is over 110 ppm are doubtless sp2 hybridized. There must be an even 
number of sp2 atoms in a molecule and therefore one of the oxygen atoms is sp2. 
Carbon 1 (LSD numbering) at δ 183.62 is thus supposed to be doubly bonded to an 
oxygen atom.  The number of hydrogen atoms that are bonded to each carbon atom 
was determined from the 1D J-modulated 13C NMR spectrum and from the 2D HSQC 
spectrum. Overall, 28 hydrogen atoms were counted, leading to the presence of 2 sp3 
oxygen atoms with no exchangeable proton. For each atom, the status and the 
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identifiers of the protons that correlate in the HMBC spectrum are reported in 
Supplementary Material 1.  Moreover, the protons of the methyl groups 17 and 19 
appear as doublets and therefore carbons 17 and 19 have a methine group as 
neighbours. In addition, the protons of the methyl groups 18 and 20 appear as singlets 
and therefore carbons 18 and 20 have quaternary carbons as neighbours. With these 
constraints, LSD produced 169 structures. All carbons with δ < 34 were then 
considered to have only carbon atoms as neighbours. LSD then produced 13 
solutions. In many of them, there were bonds between sp3 oxygens and sp3 carbons 
that were not really compatible with the measured 13C NMR chemical shifts, unless an 
epoxide were present. Only three solutions were produced after an epoxide was 
imposed. The first one contained a cyclobutanone fragment for which the chemical 
shift of C-1 was not realistic. In the second one, C-10 (LSD numbering) was bonded 
to an oxygen atom within a five-membered lactone ring. The chemical shift of C-10 at 
δ 53.17 was not realistic. The third solution was the one that was finally retained for 
compound 1. The unusual cyclic enol ester group correctly explained the strong 
chemical shift difference of C-10 and C-11 (structure 1 numbering). The LSD input 
file for this determination is supplied as Supplementary Information 2.  The molecule 
is the first example of a cembrane-derived diterpenoid with a C-2, C-12 bond, 
resulting in a spirocyclic C-12.   
The NOESY spectrum showed correlations between the H3-16 and H3-17 resonances 
and H-2, between H-2 and the H3-18 resonance, and between the H3-18 and H3-19 
resonances indicating they were on the same face of the molecule, and between H-1 
and H-3, H-3 and H-11 and between H-11 and H-7, showing they were on the 
opposite face.  Single crystal X-ray analysis (Fig 1) confirmed the structure and 
relative stereochemistry as (+)–[1R*,2S*,7S*,8S*,12R*]–7,8-epoxy-2,12-
cyclocembra-3E,10Z-dien-20,10-olide.  
 
Compound 2 was isolated as a colourless oil and identified as (+)–[1R*,10R*]-
cembra-2E,4E,7E,11Z-tetraen-20,10-olide.  The HRMS indicated a molecular formula 
of C20H28O2 and the FTIR spectrum gave an absorption band at 1745 cm-1, consistent 
with an α,β–unsaturated γ-lactone (Pavia et al., 2009).  The 13C NMR spectrum 
displayed twenty carbon resonances, including a carbonyl carbon resonance at δ 174.0 
and eight double bond carbon resonances.  The 1H NMR spectrum showed the 
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presence of four methyl group proton resonances at δ 1.70 (s), 1.78 (s) and 0.89 (d, J 
= 6.8 Hz) and 0.82 (d, J = 6.8 Hz), indicating two vinylic methyl groups (H3-19, H3-
18, respectively), and the presence of an isopropyl group, as in 1.  The two methyl 
group doublets (H3-16, H3-17) were each seen to be coupled to a methine proton 
resonance at δ 1.55 (H-15), which showed further coupling with a resonance at δ 1.72 
(m) (H-1).  The H-1 resonance was seen to be coupled with an alkene proton 
resonance at δ 5.26 (dd, J =15.4, 10.0 Hz) (H-2), which showed further coupling with 
a doublet proton resonance at δ 6.00 (d, J=15.4 Hz), ascribed to H-3.  The 
configuration of the 2- double bond was assigned as E, based on the magnitude of 
the coupling constant J2,3 = 15.4 Hz (Olsson et al., 1993). The HMBC spectrum 
showed correlations between the H-3 proton resonance and the C-1 (δ 50.1), C-2 (δ 
130.2), C-4 (δ 135.3), C-5 (δ 125.1) and C-18 (δ 19.1) resonances. The 13C NMR 
chemical shift for the C-18 methyl group of δ 19.6 indicated an E geometry for the Δ4 
- double bond, therefore the H3-18 methyl group was trans to the H-5 (δ 5.49 t J = 7.5, 
15.0 Hz) alkene proton (Crombie et al., 1975, Lange et al., 1986, Olsson et al., 1993, 
Pudhom et al., 2007). The H-5 resonance showed coupling with two H-6 proton 
resonances (δ 2.41 (m) and 3.05 (m)), which, in turn, showed coupling with the H-7 (δ 
5.10, d, J=9.5 Hz) alkene proton resonance.  The H-7 resonance showed correlations 
in the HMBC spectrum with the C-6 (δ 26.4), C-19 (δ 18.0) and C-9 resonances (δ 
41.9). The chemical shift for C-19 (δ 18.0) indicated an E geometry for the Δ7-double 
bond (Lange et al., 1986). The H2-9 resonances (δ 2.78, d, J = 14.5 Hz and 2.46, m) 
were seen to be coupled with the H-10 resonance (δ 5.04, br s, W1/2 = 8.1 Hz) which 
showed further coupling with H-11 of the α,β–unsaturated γ-lactone.  The lactone 
carbonyl carbon showed correlations in the HMBC spectrum with the overlapped H2-
13 resonances (δ 2.33, m). The H2-13 resonances showed coupling with the two H-14 
resonances (δ 2.41 (m), 1.38 (m)), which showed coupling with the previously 
assigned H-1 resonance. The H3-18 and H3-19 methyl groups were placed on the β 
face of the molecule as for compound 1, and, following compound 1, where the 
stereochemistry at C-1 was determined to be R, the isopropyl group was placed in the 
β–orientation.  Note that it is the conformation which the molecule adopts that results 
in such substituents, attached to sp2 carbons, pointing above or below the general 
plane of the molecule. The H-10 proton was determined to be in the β-configuration 
due to an observed correlation in the NOESY spectrum with the H3-19 proton 
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resonance.  The optical rotation for compound 2 was found to be +23.77.  Compound 
2 was identified as (+)–[1R*,10R*]-cembra-2E,4E,7E,11Z-tetraen-20,10-olide. 
 
Compounds 3 and 4 were found to be C-4 epimers and HRMS analysis indicated a 
molecular formula of C20H30O3. They differed from compound 2 in having a hydrated 
4-double bond. The IR spectrum of 3 showed a carbonyl stretch at 1738 cm-1, 
indicating an ,-unsaturated 5-membered lactone (Pavia et al., 2009) and a O-H 
stretch band at 3411 cm -1. A tertiary hydroxyl group was present at C-4 ( 72.5), and 
the H3-18 methyl group proton resonance now occurred at  1.37.  
 
The relative stereochemistry at the C-1, C-4 and C-10 chiral centres was assigned 
using the NOESY experiment and by comparisons with compound 1.  The 
stereochemistry at C-1 was arbitrarily assumed to be the same as for compound 1, and 
H-1 was assigned the -configuration. The H-1 proton resonance showed a 
correlation in the NOESY spectrum with the C-4 tertiary hydroxy group proton 
resonance at δ 4.36 (s) when the spectrum was acquired in DMSO-d6.  This hydroxy 
group was therefore placed in the α-orientation and hence the H3-18 (δ1.37) methyl 
group proton was assigned as β.   A correlation seen between the H3-18 methyl group 
proton resonance and the isopropyl group (H-15 and H3-16) in the NOESY spectrum 
confirmed this. The H3-19 methyl group proton resonance (δ1.67, s) showed a 
correlation with the β–orientated H3-18 resonance and the H-10 (δ5.03, br t, W1/2 = 
19.6 Hz) oxymethine proton resonance, hence H-10 was also determined to be β–
configured.  The 13C NMR chemical shift of the C-19 methyl group of δ16.5 (< 20 
ppm) (Lange et al., 1986) and the absence of a correlation between the H-7 (δ5.37, t,  
J=7.5 Hz) proton resonance and the H3-19 (δ1.67, s) methyl group proton resonance 
in the NOESY spectrum indicated that the C-7 (δ131.1) , C-8 (δ129.4) double bond 
was in the E configuration. Compound 3 was identified as (+)–[1R*,4S*,10R*]-4-
hydroxycembra-2E, 7E,11Z-trien-20,10-olide. 
 
Compound 4 was found to be (-)–[1R*,4R*,10R*]-4-hydroxycembra-2E,7E,11Z-trien-
20,10-olide.  The 13C NMR chemical shifts for compound 4 were found to be very 
similar to those of  compound 3, except for the C-18 carbon resonance at δ 30.3 
(δ28.2 for 3) and C-4 resonance at δ73.6 (δ72.5 for 3).  The H-1 (δ1.58) proton 
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resonance was assigned as α, as in compound 1. The presence of a correlation 
between the H-1 proton resonance and the H3-18 methyl group proton resonance in 
the NOESY spectrum allowed for the assignment of the α-orientation of the H3-18 
methyl group. Based on the 13C NMR chemical shift for C-19 (δ16.5 < 20 ppm) 
(Lange et al., 1986) the H3-19 methyl was also placed on the β-face of the molecule 
as in compound 1-3. The H3-19 proton resonance showed a correlation with the H-10 
(δ5.03, br s, W1/2=19.9 Hz) proton resonance, indicating it was also in the β–
orientation.  The optical rotation for this compound was found to be -82.93.  
Compound 4 was identified as (-)–[1R*,4S*,10R*]-4-hydroxycembra-2E,7E,11Z-
trien-20,10-olide. 
 
Compounds 1 and 3 were screened against the PEO1 and PEO1TaxR ovarian cancer 
cell lines and were found to have lower potency than paclitaxel (Table 2). However, 
sensitivity of taxane sensitive and taxane resistant cells was similar when treated with 
compounds 1 and 3. This could point to a tubulin binding site that is different to that 
for paclitaxel. Moreover, the data imply that compounds 1 and 3 are not recognized 
by the multidrug resistance (MDR) transporter expressed in the PEO1TaxR cells, 
which is an important property that deserves further investigation.  Experiments were 
repeated using stock solution which had been stored at 4o for four days, and the 
decrease in activity demonstrated compound instability.  Furanocembranoids from 
Croton oblongifolius have been shown to be active against BT474 (human breast 
ductol carcinoma), CHAGO (human undifferentiated lung carcinoma), Hep-G2 
(human liver hepatoblastoma), KATO-3 (human gastric carcinoma), and SW-620 
(human colon adrenocarcinoma) cell lines (Pudhom et al., 2007) and neocrotonal, 
isolated from the same source exhibited cytotoxicity against P-388 cells in vitro 
(Roengsumran et al., 1999) 
 
 
3. Experimental 
3.1 General experiment procedures 
1D and 2D NMR spectra were recorded in CDCl3 on a 500 MHz Bruker AVANCE 
NMR (University of Surrey) instrument at room temperature. Chemical shifts (δ) are 
expressed in ppm and were referenced to the solvent resonances at 7.26 and 77.23 
ppm for 1H and 13C NMR respectively. ESI mass spectra were recorded on a Bruker 
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MicroToF mass spectrometer using an Agilent 1100 HPLC to introduce samples 
(University of Oxford). Optical rotaions  were determined in CHCl3 on a JASCO P-
1020 polarimeter (University of Surrey). FTIR spectra were recorded using a Perkin-
Elmer (2000) spectrometer.  
 
 3.2 Plant material 
Stem bark of Croton gratissimus Burch. var. gratissimus was collected from a mature 
tree cultivated on the campus of the University of KwaZulu-Natal, Durban, South 
Africa, identified by N.R. Crouch and a voucher retained for verification purposes 
(Crouch 1051, NH). 
 
3.3 Extraction and isolation of compounds 
The ground stem bark (1570 g) of C. gratissimus was extracted using a Soxhlet 
apparatus for 48 h successively using hexane, methylene chloride, ethyl acetate and 
methanol. After evaporation of the solvent in vacuo the following extracts were 
obtained: hexane (19.53 g), methylene chloride (18.29 g), ethyl acetate (20.26 g) and 
methanol (57.79 g). The hexane and methylene chloride extracts were examined in 
this study.  Column chromatography over silica gel (Merck 9385) using a 5 cm 
diameter gravity column, collecting fractions (75 ml each) using a hexane/methylene 
chloride step gradient starting with 100% hexane and gradually increasing the 
methylene chloride concentration to 100%, followed by 5% methanol in methylene 
chloride, was used to separate the constituents.  Final purification was undertaken 
using 1 cm diameter gravity column.  
 
The hexane and methylene chloride extracts yielded compound 1 (Fraction 192, 6.1 
mg, 50% hexane/50% CH2Cl2), 2, (Fractions 18–25, 23.0 mg, 80% hexane/20% 
CH2Cl2) 3, (Fraction 227, 12.0 mg, 100% CH2Cl2), 4, (Fraction 145, 6.8 mg, 100% 
CH2Cl2), lupeol (Fraction 223, 20.3 mg, 100% CH2Cl2), 4(15)-eudesmene-1,6-diol 
(Fraction 227, 7.8 mg, 100 % CH2Cl2) and -glutinol (Fraction 100, 15.0 mg, 100% 
CH2Cl2). The identity of 4(15)-eudesmene-1,6-diol  and -glutinol were confirmed 
by comparison of acquired NMR data against literature values (Sun et al., 2004; Olea 
et al., 1993). NMR data for compounds 1-4 is given in Table 1. 
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3.3.1 (+)–[1R*,2S*,7S*,8S*,12R*]–7,8-Epoxy-2,12-cyclocembra-3E,10Z-dien-20,10-
olide (1). White needle-like crystals; [α]D23.6 +39.5 (c  0.0022, CHCl3); IR  νmax 
(NaCl) cm-1 3103, 2964, 2874 cm-1 (C – H stretches) and 1777 cm-1 (C = O stretch), 
1H (500 MHz, CDCl3) and 13C NMR (125 MHz, CDCl3) spectroscopic data, see Table 
1; HRESIMS m/z 339.1921 [M + Na]+ (calc. for C20H28O3Na 339.193615). 
 
3.3.2 (+)–[1R*,10R*]-Cembra-2E,4E,7E,11Z-tetraen-20,10-olide (2) 
Colourless oil; [α]D23.6 +23.77 (c 0.0042, CHCl3); IR  νmax (NaCl) cm-1 2952, 2918, 
2845 (C – H stretch) and 1745 (C = O stretch), (500 MHz, CDCl3) and 13C NMR (125 
MHz, CDCl3) spectroscopic data, see Table 1; HRESIMS m/z 323.1980 [M + Na]+ 
(calc. for C20H28O2Na 323.19870). 
 
3.3.3 (+) –[1R*,4S*,10R*]-4-Hydroxycembra-2E,7E,11Z-trien-20,10-olide (3) 
Yellow oil; [α]D23.6 +65.0 (c 0.0018, CHCl3); IR  νmax (NaCl) cm-1 3411 (O – H 
stretch) and 1738 (C = O stretch); 1H (500 MHz, CDCl3) and 13C NMR (125 MHz, 
CDCl3) spectroscopic data, see Table 1; HRESIMS m/z 341.2079 [M + Na]+ (calc. for 
C20H30O3Na 341.209265). 
 
3.3.4 (-)–[1R*,4R*,10R*]-4-Hydroxycembra-2E,7E,11Z-trien-20,10-olide (4) 
Colourless oil; [α]D23.6 -82.93 (c 0.0061, CHCl3); IR  νmax (NaCl) cm-1 3433 (O – H 
stretch) and 1736 (C = O stretch); 1H (500 MHz, CDCl3) and 13C NMR (125 MHz, 
CDCl3) spectroscopic data, see Table 1; HRESIMS m/z 341.2079 [M + Na]+ (calc. for 
C20H30O3Na 341.209265). 
 
3.4 Single-crystal X-ray Analysis of 1 
Crystal data: C20H28O3, space group P212121, a= 6.198(2) Å, b= 11.676(5) Å, 
c=24.257(9) Å, V= 1755.5(11) Å3, Z=4, D (calc) = 1.197 g/cm3, λ (Mo Kα) ) 0. 
71073 Å. Crystallographic data for compound  1 were collected at the University of 
Bristol X-ray Crystallography service a Bruker-Apex CCD diffractometer with Mo-
Ka X-ray radiation (λ = 0.71073 Å) . Data were corrected for absorption using 
empirical methods (SADABS) (Bruker, 2004) based on symmetry-equivalent 
reflections combined with measurements at different azimuthal angles. The crystal 
structure was solved and refined by direct methods against all F2 values using the 
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SHELXTL suite of programs and refined by least squares on weighted F2 values for 
all reflections (see Supplementary Information 3) (Sheldrick, 2008). All non-
hydrogen atoms were assigned anisotropic displacement parameters and refined 
without positional constraints.  All the hydrogen atoms were located in the electron 
density difference map, and refined with appropriate distance restraints. The positions 
of the methyl hydrogen atoms were assigned by a rotating group refinement with 
fixed, idealised C-H distances.  All other hydrogen atoms were constrained to ideal 
geometries.  The hydrogen atoms were assigned isotropic displacement parameters 
equal to 1.5 times (methyl hydrogen atoms) or 1.2 times (all other hydrogen atoms) 
that of their parent atom. Refinement proceeded smoothly to give the residuals shown 
in Supplementary Information 3. A total of 1695 reflections were observed. In the 
absence of heavy atom in the structure, Friedel pairs were not collected, and the 
absolute configuration of the structure 1 was not determined. 
 
3.5 Screening 
All tissue culture reagents were obtained from Sigma Aldrich (Poole, UK), unless 
stated otherwise. The PEO1 ovarian cancer cell line was originally developed by 
Langdon et al. and obtained from Prof F. Balkwill (formerly of ICRF laboratories, 
Lincoln Inn Fields, London, UK). The PEO1TaxR (paclitaxel resistant) cell line was 
derived in-house and possesses approximately 12- fold resistance to its inducing agent 
(referred to in Coley et al., 2006). PEO1 cell lines were cultured as monolayers in 
RPMI-1640 medium supplemented with 10% foetal calf serum (heat inactivated, 
obtained from Invitrogen, Paisley, UK) and 2 mM Glutamax (Invitrogen). Cells in 
monolayer culture were subjected to trypsinisation (trypsin-EDTA solution; Sigma 
Aldrich) prior to use in cytotoxicity testing (see below). 
 
Working stock solutions of compounds 1 and 3 were prepared by dissolving 
compounds in chloroform to give a concentrated solution of 50 mM. Cytotoxicity was 
determined by means of the colorimetric assay MTT (3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenyltetrazolium bromide). Cultured cell monolayers were reduced to a single 
cell suspension (as described above) and then seeded into 96-well tissue culture plates 
at a density of 6 x 103 cells per well for all cell lines. This was calculated to allow for 
exponential growth of the cultures throughout the incubation period. Cells were 
allowed to settle for 24 h, under standard culture incubation conditions and then drug 
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treated in quadruplicate with a dose range spanning 2-logs of drug concentration, each 
drug aliquot being administered in a 50 l volume. All drug dilutions were carried out 
in complete culture medium. After 72 h incubation under standard culture conditions 
MTT solution (5 mg/ml in PBS) was added in a 20 l volume and incubated for a 
further 4 h. The MTT/medium mixture was then removed and the resulting formazan 
crystals dissolved in 200 l of DMSO. The optical density of the purple color product 
was measured at 550 nm in a plate reading spectrophotometer. The quantity of live 
cells was expressed as T/C values by comparison with untreated control 
microcultures. The concentration of complexes that decreased absorption by 50% 
were calculated by interpolation and expressed as IC50 values.  
 
4. Supplementary information 
Supplementary data associated with this article can be found, in the online version, 
XXXXXXXXXXX. Crystallographic data for structure 1 is deposited at the 
Cambridge Crystallographic Data Centre as supplementary publication no. CCDC 
764183.  Copies of the data can be obtained free of charge on application to CCDC, 
12 UnionRoad, Cambridge CB2 1EZ, UK (Fax: + 44 1223 336033; E-mail: 
deposit@ccdc.cam.ac.uk). 
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Figure 1: ORTEP illustration for compound 1: (+)–[1R*,2S*,7S*,8S*,12R*]–7, 8-
Epoxy-2,12-cyclocembra-3E,10Z-dien-20,10-olide 
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Figure 2:  Structures of compounds 1-4.
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Table 1: 1H NMR (500 MHz) and 13C NMR (125 MHz) chemical shifts in CDCl3 for compounds 1 - 4   
 1 2 3 4 
No 13C NMR 1H NMR 13C NMR 1H NMR  13C NMR 1H NMR  13C NMR 1H NMR  
1 54.0 CH 1.70 m 50.1 CH 1.72 m 48.4 CH 1.58 m 48.7 CH 1.58 m 
2 54.8 CH 2.91 t J  = 9.6 Hz 130.2 CH 5.26 dd J = 15.4, 10.0 Hz 131.4 CH 5.41 m 130.5 CH 5.35 t J = 7.3 Hz 
3 128.5 CH 4.85 d J = 9.6 Hz 130.8 CH 6.00 d J = 15.4 Hz 138.0 CH 5.60 d  J = 15.7 Hz 138.6 CH 5.50 d J = 16.9 Hz 
4 136.0 C - 135.3 C - 72.5 C - 73.6 C - 
5α 38.5 CH2 2.23 dd J  = 3.9, 8.8 Hz 125.1 CH 5.49 t J = 7.5 Hz 43.7 CH2 1.92 m 43.8 CH3 1.85 m 
5β      1.51 m  1.58 m 
6α 23.2 CH2 1.87 m 26.4 CH2 2.41 m  25.6 CH2 2.34 m 25.7 CH2 2.40 m 
6β  1.57 m  3.05 m  1.59 m  2.30 m 
7α 63.0 CH 2.64 d J = 9.9 Hz 129.1 CH 5.10 d J = 9.6 Hz 131.1 CH 5.37 t J = 7.5 Hz 129.5 CH 5.51 m 
8 61.9 C - 128.1 C - 129.4 C - 129.9 C - 
9α 39.0 CH2 1.98 d J = 13.5 Hz 41.9 CH2 2.46 m  44.7 CH2 2.07 dd J = 2.6,12.7 Hz  44.6 CH2 2.10 dd J = 10.2, 12.6 Hz  
9β  2.86 q J = 4.3 Hz  2.78 d J = 14.6 Hz   2.80 dd J = 7.3,12.7 Hz   2.81 dd J = 5.4, 12.6 Hz  
10 151.2 C - 81.8 CH 5.04 br s W1/2 = 8.1 Hz 80.3 CH 5.03 br s W1/2 = 19.6 Hz 80.3 CH 5.03 br s W1/2 = 19.9 Hz 
11 110.6 CH 5.05 br s W1/2 = 2.8 Hz 151.3 CH 6.80 s 149.6 CH 6.98 d J = 1.6 Hz 149.5 CH 7.02 d J = 1.7 Hz 
12 58.3 C - 132.5 C - 133.6 C - 133.9 C - 
13α 33.3 CH2 1.78 m 25.1 CH2 2.33 m 22.7 CH2 2.20 m 23.4 CH2 2.00 m 
13β  2.14 m      2.35 m 
14α 28.2 CH2 1.84 m 26.5 CH2 2.41 m  28.1 CH2 1.94 m 28.7 CH2 1.85 m 
14β  1.67 m  1.38 m  1.49 m  1.58 m 
15 29.9 CH 1.68 m 33.0 CH 1.55 m 33.9 CH 1.60 m 34.0 CH 1.58 m 
16 18.8 CH3 0.85 d J = 6.6 Hz 20.0 CH3 0.82 d J = 6.8 Hz 19.6 CH3 0.84 d J = 6.5 Hz 19.5 CH3 0.82 d J = 6.4 Hz 
17 22.0 CH3 0.92 d J = 6.6 Hz 20.9 CH3 0.89 d J = 6.8 Hz 20.4 CH3 0.89 d J = 6.5 Hz 20.6 CH3 0.88 d J = 6.4 Hz 
18 15.1 CH3 1.52 d J = 1.2 Hz 19.6 CH3 1.78 s 28.2 CH3 1.37 s 30.3 CH3 1.30 s 
19 19.2 CH3 1.42 s 18.0 CH3 1.70 s 16.5 CH3 1.67 s 16.5 CH3 1.67 s 
20 183.6 C - 174.0 C - 174.2 C - 174.2 C - 
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Table 2: Chemosensitivity testing in taxane sensitive (PEO1) and resistant 
PEO1TaxR human ovarian cancer cells (data shown are IC50 drug 
concentrations in nM amounts) for compounds 1 and 3.  
 
Compound PEO1 PEO1TaxR Resistance Factor 
1 132  200  1.5 
3 125  135  < 1.0 
Paclitaxel 2.3 30.5 13.3 
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SUPPLEMENTARY INFORMATION 1 
Table 1. Atom and NMR correlation description of compound 1, used as input to the 
LSD structure generator. 
 
LSD  
Atom # 
Statusa 
HMBC  
correlationb 
Atom #  
in 1 
1 C sp2 0 5, 9, 13 20 
2 C sp2 0 5, 11 10 
3 C sp2 0 9, 12, 20 4 
4 C sp2 1 9, 12, 20 3 
5 C sp2 1 9, 11, 13 11 
6 C sp3 1 11, 12, 18 7 
7 C sp3 0 6, 11, 16, 18 8 
8 C sp3 0 5, 9, 13 12 
9 C sp3 1 –   2 
10 C sp3 1 4, 9, 17, 19 1 
11 C sp3 2 18 9 
12 C sp3 2 4, 6, 16 5 
13 C sp3 2 – 13 
14 C sp3 1 9, 19 15 
15 C sp3 2 13 14 
16 C sp3 2 6, 12 6 
17 C sp3 3 19 16 
18 C sp3 3 11 19 
19 C sp3 3 17 17 
20 C sp3 3 4, 12 18 
21 O sp2 0 – – 
22 O sp3 0 – – 
23 O sp3 0 – – 
aThe status is defined by the element, 
hybridization state, multiplicity triplet. bHydrogen 
atom numbers. 
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SUPPLEMENTARY INFORMATION 2 
 
Computer file for the LSD-assisted structure elucidation of compound 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
; Compound 1 
; Cembranoid from 
; Croton gratissimus 
 
; CDCl3 77.233 
 
; Atom 1 is a C, sp2,  
; 0 H attached. 
MULT 1 C 2 0 ; 183.62 
MULT 2 C 2 0 ; 151.16 
MULT 3 C 2 0 ; 135.96 
MULT 4 C 2 1 ; 128.50 
MULT 5 C 2 1 ; 110.65 
MULT 6 C 3 1 ; 63.01 
MULT 7 C 3 0 ; 61.92 
MULT 8 C 3 0 ; 58.32 
MULT 9 C 3 1 ; 54.82 
MULT 10 C 3 1 ; 53.97 
MULT 11 C 3 2 ; 39.03 
MULT 12 C 3 2 ; 38.48 
MULT 13 C 3 2 ; 33.33 
MULT 14 C 3 1 ; 29.92 
MULT 15 C 3 2 ; 28.17 
MULT 16 C 3 2 ; 23.19 
MULT 17 C 3 3 ; 22.02 
MULT 18 C 3 3 ; 19.22 
MULT 19 C 3 3 ; 18.75 
MULT 20 C 3 3 ; 15.15 
MULT 21 O 2 0 
MULT 22 O 3 0 
MULT 23 O 3 0 
 
; C4 is bonded to H4 
HMQC 4 4 
HMQC 5 5 
HMQC 6 6 
HMQC 9 9 
HMQC 10 10 
HMQC 11 11 
HMQC 12 12 
HMQC 13 13 
HMQC 14 14 
HMQC 15 15 
HMQC 16 16 
HMQC 17 17 
HMQC 18 18 
HMQC 19 19 
HMQC 20 20 
 
 
 
 
; C1 correlates 
; with H5 in HMBC 
HMBC 1 5 
HMBC 1 9 
HMBC 1 13 
HMBC 2 5 
HMBC 2 11 
HMBC 3 9 
HMBC 3 12 
HMBC 3 20
HMBC 4 9 
HMBC 4 12 
HMBC 4 20 
HMBC 5 9 
HMBC 5 11 
HMBC 5 13 
HMBC 6 11 
HMBC 6 12 
HMBC 6 18 
HMBC 7 11 
HMBC 7 6 
HMBC 7 16 
HMBC 7 18 
HMBC 8 5 
HMBC 8 9 
HMBC 8 13 
HMBC 10 4 
HMBC 10 9 
HMBC 10 17 
HMBC 10 19 
HMBC 11 18 
HMBC 12 4 
HMBC 12 6 
HMBC 12 16 
HMBC 14 9 
HMBC 14 19 
HMBC 15 13 
HMBC 16 6 
HMBC 16 12 
HMBC 17 19 
HMBC 18 11 
HMBC 19 17 
HMBC 20 4 
HMBC 20 12 
 
; L1: quaternary C 
QUAT L1 
 
; L2: methine C 
CH   L2 
; Atoms 17 and 19 are 
; bonded to a methine C 
PROP 17 1 L2  
PROP 19 1 L2 
 
; Atoms 18 and 20 are 
; bonded to a quat. C 
PROP 18 1 L1 
PROP 20 1 L1 
 
; the carbonyl group 
BOND 1 21 
 
; L7: atoms with  
; all carbon neighbours 
LIST L7 13 14 15 16 22 23 
 
; L8: all carbon atoms 
CARB L8 
 
; Each atom in L7 
; has all (0) its 
; neighbours in L8. 
; Next line may be 
; commented (;) 
PROP L7 0 L8 
 
; remove substructure 
; constraint. 
; Next line may be 
; commented (;) 
SUBS 0 
 
; Cyclopropane description 
; Sub-atom S1 is a C, sp3, 
; with 0 or 1 or 2 H 
; atom attached 
SSTR S1 C 3 (0 1 2) 
SSTR S2 C 3 (0 1 2) 
SSTR S3 O 3 0 
 
; Sub-atom bonds 
LINK S1 S2 
LINK S1 S3 
LINK S2 S3 
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SUPPLEMENTARY INFORMATION 3 
Crystal data and intensity collection for compound 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Empirical formula C20 H28 O3 
Formula weight 316.42 
Temperature 100(2) K 
Wavelength 0.71073 Å 
Crystal system Orthorhombic 
Space group   P 21 21 21 
Unit cell dimensions a  = 6.198(2) Å α = 90° 
 b = 11.676(5) Å β = 90° 
 c = 24.257(9) Å δ = 90° 
Volume   1755.5(11) Å3 
Z  4 
Density (calculated)  1.197 Mg/m3 
Absorption coefficient  0.079 mm-1 
F(000)  688 
Crystal size (mm)  0.247 x 0.189 x 0.06 
θ range for data collection  1.68 to 26.56° 
Index ranges   -7<=h<=7, -14<=k<=14, -30<=l<=30 
Reflections collected 11828 
No. of  Friedel pairs 1695 
Independent reflections   2113 [Rint = 0.0704] 
Completeness to θ =28.56°, 99.9 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.993 and 0.982 
Refinement method  Full-matrix least-squares on F2 
Data / restraints / parameters 2136 / 0 / 212 
Goodness-of-fit on F2 S 1.042 
R indices [for 1665reflections, 
I>2δ(I)] 
R1 = 0.0386, wR2 = 0.0801 
R indices  (for all 2136 data) R1 = 0.0587, wR2 = 0.0878 
Absolute structure (Flack) 
parameter 0.03(2) 
Largest diff. peak and hole 0.183 and -0.181 eÅ-3 
